Reimbursement for biomarker testing billed on CMS 1500/UB04
Governs reimbursement methodology for biomarker testing associated with autoimmune rheumatic disease for UnitedHealthcare Medicare Advantage plans; applies to services billed on UB04 (CMS 1450) and CMS 1500 forms and their electronic equivalents.
No material clinical or coverage changes in this revision.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.